Taro Pharmaceutical Industries Ltd.Yakum, Israel (Pink Sheets: TAROF)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Taro Income Statement

All amounts in millions of except per share amounts.
View: Annual | Quarterly
Dec 08* Dec 05 Dec 04
Revenue 341.9 297.7 284.1
Cost of Goods Sold 154.8 128.7 119.4
Gross Profit 187.2 169.1 164.7
Gross Profit Margin 54.7% 56.8% 58.0%
SG&A Expense 92.1 108.1 123.3
Depreciation & Amortization 23.0 25.3 19.6
Operating Income 78.0 15.2 (0.5)
Operating Margin 22.8% 5.1% --
Nonoperating Income 1.2 0.0 0.0
Nonoperating Expenses (16.6) -- --
Income Before Taxes 61.4 7.3 (6.9)
Income Taxes 10.0 1.6 (17.0)
Net Income After Taxes 51.4 5.7 10.1

Continuing Operations 51.4 5.7 11.1
Discontinued Operations -- -- --
Total Operations 51.4 5.7 11.1
Total Net Income 51.4 5.7 11.1
Net Profit Margin 15.0% 1.9% 3.9%

Diluted EPS from Total Net Income ($) 1.27 0.19 0.37
Dividends per Share 0.00 0.00 0.00
© 2009 Morningstar, Inc. Financial Data provided by Morningstar

Copyright © 2009, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy